VIGH receives grant to build research capacity in Sierra Leone

The Vanderbilt Institute for Global Health (VIGH) has been awarded a five-year, $1.2 million federal grant from the Fogarty International Center of the National Institutes of Health to evaluate and build a research capacity program in implementation science and clinical trial management to address Ebola, Lassa fever and other viral hemorrhagic fevers (VHF) in Sierra Leone. The Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL) will address gaps and improve existing research capacity at in-country partner institutions. 

VIGH receives renewal to expand research ethics in Mozambique

Vanderbilt Institute for Global Health (VIGH) has been awarded a five-year, $1.2 million renewal of its Mozambique Collaborative Research Ethics Education Program supported by the Fogarty International Center of the NIH. In Portuguese, the Formação Colaborativa em Etica na Pesquisa or FoCEP Program is tailored to Portuguese speaking Africa.

Lloyd Mulenga, PhD, MMed, MBChB, MSc

Lloyd
Mulenga
MBCHB, MSc, MMED, PhD
National HIV Program Coordinator
Ministry of Health, Zambia
Associate Director of Infectious Diseases
University of Zambia School of Medicine
Adjunct Assistant Professor
Department of Medicine

Lloyd Mulenga, PhD, MMed, MBChB, MSc is an Infectious Disease and Internal Medicine Specialist, practicing at the University Teaching Hospital, in Lusaka, Zambia and the Director of Infectious Diseases for the Ministry of Health. He is the lead infectious diseases physician for the Zambian COVID-19 clinical response. He currently serves on the United States National Institute of Health (NIH) Data and Safety Monitoring Boards for the Division of AIDS National Institute of Allergy and Infectious Diseases (NIAID), the WHO Guidelines Development Group and the WHO HIV Drug Resistance Network (HIVResNet). His research focuses on HIV and clinical outcomes and drug resistance, HIV and non-communicable diseases (kidney, cardiovascular and diabetes) and infectious diseases epidemiology and clinical outcomes including SARS-CoV-2, tuberculosis and hepatitis. 

As a physician-scientist-policymaker, Dr. Mulenga leads infectious disease activities at the University of Zambia, in the university’s teaching hospital and lab, as well as within his country’s health ministry. In addition to conducting research and publishing in nearly 50 journals, he also has engaged in science diplomacy, delivered a plenary presentation on the state of HIV in Africa at the U.N., and participated in a WHO review of the agency’s HIV treatment guidelines.

Dr. Mulenga earned his PhD through the Fogarty-supported University of Zambia-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research and completed his medical education at the Univeristy of Zambia. 

lloyd.b.mulenga.1@vumc.org
Mulenga

Wilbroad Mutale, Ph.D., M.B.Ch.B.

Wilbroad
Mutale
M.B.Ch.B, Ph.D.
Professor
University of Zambia School of Public Health
Adjunct Associate Professor
Department of Medicine

Wilbroad Mutale, M.B.Ch.B, Ph.D., is a full-time faculty member at the University of Zambia School of Public Health and an Adjunct Associate Professor of Medicine at the Vanderbilt University School of Medicine. Dr. Mutale has over 16 years of work experience in Sub-Saharan Africa working as a manager, clinician, and researcher. His primary research interests are the implementation of complex health systems interventions and health system strengthening in low-income settings. He has worked on a variety of research projects on topics such as non-communicable diseases and prevention of mother to child transmission of HIV. 

wmutale@yahoo.com
Mutale

Why Mentorship Matters in Low- and Middle-Income Countries

"Mentors are teachers but not all teachers are mentors." Lackson Kasonka, Senior Mentor The next generation of global health researchers, scientists and practitioners are benefiting from a mentoring program at the University of Zambia (UNZA) in Lusaka with the help of colleagues from the Vanderbilt Institute for Global Health (VIGH) and the University of North Carolina at Chapel Hill, with support from the Fogarty International Center.